Literature DB >> 342858

Neuroleptic attenuation of intracranial self-stimulation: reward or performance deficits?

R A Wise.   

Abstract

Mesh:

Substances:

Year:  1978        PMID: 342858     DOI: 10.1016/0024-3205(78)90331-4

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  5 in total

1.  Preliminary evidence that negative symptom severity relates to multilocus genetic profile for dopamine signaling capacity and D2 receptor binding in healthy controls and in schizophrenia.

Authors:  Sarah A Eisenstein; Ryan Bogdan; Ling Chen; Stephen M Moerlein; Kevin J Black; Joel S Perlmutter; Tamara Hershey; Deanna M Barch
Journal:  J Psychiatr Res       Date:  2016-11-17       Impact factor: 4.791

2.  Qualitative differences between C57BL/6J and DBA/2J mice in morphine potentiation of brain stimulation reward and intravenous self-administration.

Authors:  Greg I Elmer; Jeanne O Pieper; Lindsey R Hamilton; Roy A Wise
Journal:  Psychopharmacology (Berl)       Date:  2009-12-15       Impact factor: 4.530

3.  Characterization of the effects of serotonin on the release of [3H]dopamine from rat nucleus accumbens and striatal slices.

Authors:  B Nurse; V A Russell; J J Taljaard
Journal:  Neurochem Res       Date:  1988-05       Impact factor: 3.996

4.  A comparison of some behavioural effects of amphetamine and electrical brain stimulation of the mesolimbic dopamine system in rats.

Authors:  G D D'Mello
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

5.  The discriminative stimulus properties and detection thresholds of intracranial self-stimulation: effects of d-amphetamine, morphine, and haloperidol.

Authors:  G J Schaefer; R P Michael
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.